186 related articles for article (PubMed ID: 10653662)
1. Potent and selective inhibition of zinc aminopeptidase A (EC 3.4.11.7, APA) by glutamyl aminophosphinic peptides: importance of glutamyl aminophosphinic residue in the P1 position.
Georgiadis D; Vazeux G; Llorens-Cortes C; Yiotakis A; Dive V
Biochemistry; 2000 Feb; 39(5):1152-5. PubMed ID: 10653662
[TBL] [Abstract][Full Text] [Related]
2. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
[TBL] [Abstract][Full Text] [Related]
3. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors.
Chauvel EN; Coric P; Llorens-Cortès C; Wilk S; Roques BP; Fournié-Zaluski MC
J Med Chem; 1994 Apr; 37(9):1339-46. PubMed ID: 7909847
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols.
Chauvel EN; Llorens-Cortès C; Coric P; Wilk S; Roques BP; Fournié-Zaluski MC
J Med Chem; 1994 Sep; 37(18):2950-7. PubMed ID: 7915326
[TBL] [Abstract][Full Text] [Related]
6. Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics.
Chen H; Noble F; Coric P; Fournie-Zaluski MC; Roques BP
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):12028-33. PubMed ID: 9751784
[TBL] [Abstract][Full Text] [Related]
7. Study of asparagine 353 in aminopeptidase A: characterization of a novel motif (GXMEN) implicated in exopeptidase specificity of monozinc aminopeptidases.
Iturrioz X; Rozenfeld R; Michaud A; Corvol P; Llorens-Cortes C
Biochemistry; 2001 Dec; 40(48):14440-8. PubMed ID: 11724556
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.
Tieku S; Hooper NM
Biochem Pharmacol; 1992 Nov; 44(9):1725-30. PubMed ID: 1360211
[TBL] [Abstract][Full Text] [Related]
9. Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme.
David C; Bischoff L; Meudal H; Mothé A; De Mota N; DaNascimento S; Llorens-Cortes C; Fournié-Zaluski MC; Roques BP
J Med Chem; 1999 Dec; 42(25):5197-211. PubMed ID: 10602705
[TBL] [Abstract][Full Text] [Related]
10. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids.
Wilk S; Thurston LS
Neuropeptides; 1990 Jul; 16(3):163-8. PubMed ID: 1982017
[TBL] [Abstract][Full Text] [Related]
12. Structure of aminopeptidase N from Escherichia coli complexed with the transition-state analogue aminophosphinic inhibitor PL250.
Fournié-Zaluski MC; Poras H; Roques BP; Nakajima Y; Ito K; Yoshimoto T
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):814-22. PubMed ID: 19622865
[TBL] [Abstract][Full Text] [Related]
13. Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities.
Chen H; Noble F; Mothé A; Meudal H; Coric P; Danascimento S; Roques BP; George P; Fournié-Zaluski MC
J Med Chem; 2000 Apr; 43(7):1398-408. PubMed ID: 10753476
[TBL] [Abstract][Full Text] [Related]
14. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III.
Réaux A; de Mota N; Zini S; Cadel S; Fournié-Zaluski MC; Roques BP; Corvol P; Llorens-Cortès C
Neuroendocrinology; 1999 May; 69(5):370-6. PubMed ID: 10343178
[TBL] [Abstract][Full Text] [Related]
15. The characteristics, functions and inhibitors of three aminopeptidases belonging to the m1 family.
Luan Y; Ma C; Wang Y; Fang H; Xu W
Curr Protein Pept Sci; 2012 Aug; 13(5):490-500. PubMed ID: 22954453
[TBL] [Abstract][Full Text] [Related]
16. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
17. Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase.
Yiotakis A; Lecoq A; Nicolaou A; Labadie J; Dive V
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):323-7. PubMed ID: 7945258
[TBL] [Abstract][Full Text] [Related]
18. A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A.
Vazeux G; Iturrioz X; Corvol P; Llorens-Cortes C
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):407-13. PubMed ID: 9716499
[TBL] [Abstract][Full Text] [Related]
19. Histidine 450 plays a critical role in catalysis and, with Ca2+, contributes to the substrate specificity of aminopeptidase A.
Iturrioz X; Vazeux G; Célérier J; Corvol P; Llorens-Cortès C
Biochemistry; 2000 Mar; 39(11):3061-8. PubMed ID: 10715127
[TBL] [Abstract][Full Text] [Related]
20. A tyrosine residue essential for catalytic activity in aminopeptidase A.
Vazeux G; Iturrioz X; Corvol P; Llorens-Cortès C
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):883-9. PubMed ID: 9581570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
